The Cigna Group CI

Revenue Intelligence Report • 32 quarters of SEC filing data • Updated 2026-03-06

The Cigna Group's revenue is primarily driven by its effective management of selling, general, and administrative (SG&A) expenses, with each dollar spent generating an impressive $24.48 in long-run revenue. Despite a recent holdout test indicating a 6.5% forecasting error, the company's model demonstrates a strong accuracy with a 5.8% MAPE. Looking ahead, the FY forecast projects a revenue decline of 9.1% year-over-year, suggesting potential challenges in maintaining growth. Investors should monitor the company's strategies to optimize spending and adapt to market conditions to enhance future revenue prospects.

Next FY Revenue
$249.78B
-9.1% YoY
SG&A Multiplier
$24.48 per $1
Model Accuracy
5.8% MAPE
Holdout validation: The model predicted $68B vs the actual $72B — an error of 6.5%.
Note: The Cigna Group does not report R&D expenses separately. This analysis uses SG&A spending only.

Revenue Forecast

CI Revenue Forecast

Quarterly Detail

QuarterModel ForecastActual95% RangeYoY GrowthStatus
Q4 2025 $68B $72B $60B – $76B +3.3% ✓ In range
Q2 2026 $65B $54B – $76B -0.7%
Q3 2026 $63B $50B – $77B -6.1%
Q4 2026 $62B $46B – $77B -11.7%
Q1 2027 $60B $43B – $77B -17.2%

How Spending Drives Revenue

CI Spending Timing
Reading this chart: Each line shows the cumulative revenue generated per $1 spent over subsequent quarters. The effect builds over 4-5 quarters as investments mature.

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch